Trials / Completed
CompletedNCT03225872
Biology of Osteosarcoma (BOOST) Registry and Biobank
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 362 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Accepted
Summary
Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.
Detailed description
Summary to include: 1. Samples of saliva, blood and/or other stored material such as slides or leftover diagnostic material. If available the investigator may ask you for deciduous (baby) teeth. 2. Questionnaire information, including health history, growth and development, physical activity and family medical history information. 3. If you have been diagnosed with a osteosarcoma or another condition the investigator is interested inthe investigator will ask you release medical record information relating to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar conditions. If this step applies to you then you will be asked to sign a separate form. 4. You may be asked to contact your biological parents and full biological siblings to ask them about participating in the study. 5. If you agree you may be contacted in the future. You will be able to decline any future information or studies at any point.
Conditions
Timeline
- Start date
- 2017-01-03
- Primary completion
- 2020-01-27
- Completion
- 2020-01-27
- First posted
- 2017-07-21
- Last updated
- 2025-12-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03225872. Inclusion in this directory is not an endorsement.